S. Kufner

发表

Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents

M. Fischer, H. Schunkert, A. Kastrati, 2017, Thrombosis and Haemostasis.

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.

W. Rottbauer, M. Fischer, H. Schunkert, 2019, The New England journal of medicine.

Carotid Artery Interventions: Thromboembolic Protection

S. Kufner, S. Cassese, M. Fusaro, 2018 .

Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.

H. Schunkert, M. Joner, A. Kastrati, 2018, Journal of the American College of Cardiology.

Impact of perfusion restoration at epicardial and tissue levels on markers of myocardial necrosis and clinical outcome of patients with acute myocardial infarction.

A. Kastrati, J. Mehilli, M. Seyfarth, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis: A pooled analysis of the Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 3 and 4 (ISAR-DESIRE 3 and

H. Schunkert, M. Joner, A. Kastrati, 2018, International journal of cardiology.

Drug-eluting Stents versus bioabsorbierbare Scaffolds

S. Kufner, S. Cassese, 2017, CardioVasc.

Long-Term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Stents in Routine Practice: 2-Year Results of the ISAR-ABSORB Registry.

H. Schunkert, M. Joner, A. Kastrati, 2017, JACC. Cardiovascular interventions.

Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis.

M. Joner, A. Kastrati, Y. Harada, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Angiographic and clinical outcomes of patients treated with everolimus‐eluting bioresorbable stents in routine clinical practice: Results of the ISAR‐ABSORB registry

H. Schunkert, M. Joner, A. Kastrati, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction.

H. Schunkert, A. Kastrati, J. Mehilli, 2014, European heart journal.

Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis

H. Schunkert, M. Joner, A. Kastrati, 2022, Clinical Research in Cardiology.

Angiographic performance of everolimus‐eluting stents for the treatment of coronary in‐stent restenosis in daily practice

H. Schunkert, M. Joner, A. Kastrati, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Six Versus Twelve Months Clopidogrel Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup Analysis

M. Fischer, H. Schunkert, A. Kastrati, 2016, Scientific Reports.

Ten-year patterns of stent thrombosis after percutaneous coronary intervention with new- versus early-generation drug-eluting stents: insights from the DECADE cooperation.

L. Räber, A. Kastrati, S. Windecker, 2022, Revista espanola de cardiologia.

U-shaped association of central pulse pressure with long-term prognosis after ST-segment elevation myocardial infarction

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Heart and Vessels.

Prognostic value of haemoglobin drop in patients with acute coronary syndromes

H. Schunkert, M. Joner, A. Kastrati, 2021, European journal of clinical investigation.

Sex differences in the outcome after percutaneous coronary intervention - A propensity matching analysis.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Cardiovascular revascularization medicine : including molecular interventions.

Prognostic value of gamma-glutamyl transferase in patients with diabetes mellitus and coronary artery disease.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, Clinical biochemistry.

Very late scaffold thrombosis after everolimus-eluting bioresorbable scaffold implantation in patients with unremarkable interim surveillance angiography.

M. Joner, A. Kastrati, R. Colleran, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Ticagrelor or Prasugrel in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

H. Schunkert, M. Joner, A. Kastrati, 2020, Circulation.

Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial.

C. Hengstenberg, H. Schunkert, A. Kastrati, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.

H. Schunkert, M. Joner, A. Kastrati, 2020, Journal of the American College of Cardiology.

Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2007, American heart journal.

Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial

A. Kastrati, J. Mehilli, F. Dotzer, 2011, Clinical Research in Cardiology.

Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes.

H. Schunkert, M. Joner, A. Kastrati, 2021, Revista espanola de cardiologia.

Alkaline Phosphatase and Prognosis in Patients with Diabetes Mellitus and Ischemic Heart Disease.

A. Kastrati, G. Ndrepepa, S. Kufner, 2022, Clinica chimica acta; international journal of clinical chemistry.

Relation of Ratio of Left Ventricular Ejection Fraction to Left Ventricular End-Diastolic Pressure to Long-Term Prognosis After ST-Segment Elevation Acute Myocardial Infarction.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, The American journal of cardiology.

Comparative prognostic value of postprocedural creatine kinase myocardial band and high‐sensitivity troponin T in patients with non‐ST‐segment elevation myocardial infarction undergoing percutaneous coronary intervention

H. Schunkert, A. Kastrati, G. Ndrepepa, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.

A. Kastrati, J. Mehilli, A. Schömig, 2012, Cardiology journal.

Increased bleeding risk during percutaneous coronary interventions by arterial hypertension

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Myocardial perfusion grade, myocardial salvage indices and long-term mortality in patients with acute myocardial infarction and full restoration of epicardial blood flow after primary percutaneous coronary intervention.

A. Kastrati, J. Mehilli, A. Schömig, 2010, Revista espanola de cardiologia.

Randomized, Double Blind Trial of 6 Versus 12 Months Of Dual Antiplatelet Therapy After DES-Implantation (ISAR-SAFE)

C. Hengstenberg, M. Fischer, H. Schunkert, 2014 .

Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique.

M. Joner, A. Kastrati, Y. Harada, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Access route and clinical outcomes after ticagrelor versus prasugrel in patients with acute coronary syndrome undergoing invasive treatment strategy.

H. Schunkert, M. Joner, A. Kastrati, 2022, Cardiovascular revascularization medicine : including molecular interventions.

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention

H. Schunkert, M. Joner, A. Kastrati, 2021, Circulation. Cardiovascular interventions.

Comparison of Vascular Closure Devices Versus Manual Compression After Femoral Artery Puncture in Women: Gender-Based Analysis of a Large Scale, Randomized Clinical Trial

H. Schunkert, A. Kastrati, I. Ott, 2018, Circulation. Cardiovascular interventions.

Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial.

C. Hengstenberg, H. Schunkert, M. Joner, 2014, JAMA.

Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.

C. Hengstenberg, H. Schunkert, M. Joner, 2017, JACC. Cardiovascular interventions.

Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial

H. Schunkert, M. Joner, A. Kastrati, 2022, Clinical Research in Cardiology.

Neointimal Modi ﬁ cation With Scoring Balloon and Ef ﬁ cacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents A Randomized Controlled Trial

C. Hengstenberg, H. Schunkert, M. Joner, 2017 .

Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis.

A. Kastrati, J. Mehilli, J. Hausleiter, 2009, JACC. Cardiovascular interventions.

Relationship of left ventricular end‐diastolic pressure with extent of myocardial ischemia, myocardial salvage and long‐term outcome in patients with ST‐segment elevation myocardial infarction

H. Schunkert, A. Kastrati, G. Ndrepepa, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry.

H. Schunkert, A. Kastrati, Y. Harada, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial

M. Hadamitzky, H. Schunkert, A. Kastrati, 2017, Journal of the American Heart Association.

Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis

H. Schunkert, M. Joner, A. Kastrati, 2022, Clinical Research in Cardiology.

Long-Term Prognostic Impact of Restenosis of the Unprotected Left Main Coronary Artery Requiring Repeat Revascularization.

H. Schunkert, A. Kastrati, J. Mehilli, 2020, JACC. Cardiovascular interventions.

Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH)

M. Hadamitzky, H. Schunkert, A. Kastrati, 2017, Circulation.

Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated?

M. Joner, A. Kastrati, Y. Harada, 2020, Revista espanola de cardiologia.

Five‐year follow‐up of polymer‐free sirolimus‐ and probucol‐eluting stents versus new generation zotarolimus‐eluting stents in patients presenting with st‐elevation myocardial infarction

A. Kastrati, Y. Harada, Raphaela Lohaus, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials.

P. Serruys, P. Jüni, A. Kastrati, 2013, International journal of cardiology.

A prospective trial of a novel low‐dose paclitaxel‐coated balloon therapy in patients with restenosis in drug‐eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In‐stent REstenosis 3A (ISAR‐DESIRE 3A)

H. Schunkert, M. Joner, A. Kastrati, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

What Treatment Should We Dare in Patients With In-Stent Restenosis?

M. Joner, A. Kastrati, S. Kufner, 2018, JACC. Cardiovascular interventions.

Drug-eluting stents for drug-eluting stent restenosis: stick with the old or switch to a new one?

A. Kastrati, S. Kufner, 2014, Coronary artery disease.

Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: results from the ISAR-DESIRE 2 trial.

M. Joner, A. Kastrati, S. Kufner, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Target and non-target vessel related events at 10 years post percutaneous coronary intervention

H. Schunkert, M. Joner, A. Kastrati, 2022, Clinical Research in Cardiology.

Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with Diabetes mellitus: a patient-level meta-analysis of randomized trials

A. Kastrati, A. Schömig, M. Sabaté, 2011, Clinical Research in Cardiology.

A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease.

A. Kastrati, A. Schömig, C. Briguori, 2011, American heart journal.

Acute coronary syndromes Prasugrel plus bivalirudin vs . clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction

H. Schunkert, A. Kastrati, J. Mehilli, 2022 .

Rotational Atherectomy or Balloon-Based Techniques to Prepare Severely Calcified Coronary Lesions.

M. Joner, A. Kastrati, M. Bossard, 2022, JACC. Cardiovascular interventions.

Stent Optimization Using Optical Coherence Tomography and Its Prognostic Implications After Percutaneous Coronary Intervention

Youssef S. Abdelwahed, L. Räber, M. Joner, 2022, Journal of the American Heart Association.

Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest – A propensity score-matched analysis

H. Schunkert, M. Joner, A. Kastrati, 2019, bioRxiv.

Diabetes mellitus and femoropopliteal in-stent restenosis.

I. Ott, S. Kufner, T. Ibrahim, 2022, VASA. Zeitschrift fur Gefasskrankheiten.

Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis.

H. Schunkert, M. Joner, A. Kastrati, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Outcome after new generation single‐layer polytetrafluoroethylene‐covered stent implantation for the treatment of coronary artery perforation

A. Kastrati, K. Mayer, S. Kufner, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Super High-Pressure Balloon versus Scoring Balloon to Prepare Severely Calcified Coronary Lesions: The ISAR-CALC Randomized Trial.

M. Joner, A. Kastrati, M. Bossard, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Circulation: Cardiovascular Interventions

H. Schunkert, M. Joner, A. Kastrati, 2022 .

Diagnosis and management of intramyocardial hematoma after coronary artery perforation: case studies of the Deutsches Herzzentrum München.

A. Kastrati, G. Ndrepepa, S. Kufner, 2016, Coronary artery disease.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial

H. Schunkert, M. Joner, A. Kastrati, 2022, Journal of the American Heart Association.

Second‐versus first‐generation “Limus”‐eluting stents in diabetic patients with coronary artery disease: A randomized comparison in setting of ISAR‐TEST‐4 trial

A. Kastrati, J. Mehilli, J. Pache, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Hypothermia in patients with acute myocardial infarction: a meta-analysis of randomized trials

H. Thiele, M. Joner, A. Kastrati, 2020, Clinical Research in Cardiology.

Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

H. Schunkert, M. Joner, A. Kastrati, 2022, Thrombosis and Haemostasis.

Covered stents for endovascular repair of iatrogenic injuries of iliac and femoral arteries.

H. Schunkert, A. Kastrati, I. Ott, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial

A. Kastrati, Y. Harada, J. Michel, 2016, Cardiovascular Diabetology.

Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials

Heribert Schunkert, Adnan Kastrati, Takeshi Kimura, 2016, The Lancet.

Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.

A. Kastrati, J. Mehilli, A. Schömig, 2010, Journal of the American College of Cardiology.

Prediction of risk for bleeding, myocardial infarction and mortality after percutaneous coronary intervention in patients with acute coronary syndromes

H. Schunkert, M. Joner, A. Kastrati, 2022, Coronary artery disease.

Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes

H. Schunkert, M. Joner, A. Kastrati, 2021, Journal of the American Heart Association.

Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions

L. Räber, A. Kastrati, S. Windecker, 2018, Circulation. Cardiovascular interventions.

High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention.

Karl-Ludwig Laugwitz, Heribert Schunkert, Ilka Ott, 2016, Journal of the American College of Cardiology.

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.

Walter Desmet, Karl-Ludwig Laugwitz, Yi Li, 2015, European heart journal.

Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial.

A. Kastrati, J. Mehilli, F. Neumann, 2010, European heart journal.

Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation

H. Schunkert, A. Kastrati, J. Mehilli, 2014, Thrombosis and Haemostasis.

Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic Stents

H. Schunkert, A. Kastrati, Y. Harada, 2016, Circulation. Cardiovascular interventions.

Association of progression or regression of coronary artery atherosclerosis with long-term prognosis.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, American heart journal.

One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.

A. Kastrati, J. Mehilli, F. Neumann, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trial.

H. Schunkert, M. Joner, A. Kastrati, 2021, European heart journal. Acute cardiovascular care.

Drug-Coated Balloons for Revascularization of Infrapopliteal Arteries: A Meta-Analysis of Randomized Trials.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, JACC. Cardiovascular interventions.

Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial.

A. Kastrati, J. Mehilli, M. Seyfarth, 2009, European heart journal.

Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus

H. Schunkert, M. Joner, A. Kastrati, 2021, Clinical Research in Cardiology.

Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis.

H. Schunkert, M. Joner, A. Kastrati, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation

L. Räber, A. Kastrati, S. Windecker, 2023, Circulation.

High-sensitivity cardiac troponin T and prognosis in patients with ST-segment elevation myocardial infarction.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2018, Journal of cardiology.

Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials

H. Schunkert, M. Joner, A. Kastrati, 2020, Clinical Research in Cardiology.

Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials

H. Schunkert, A. Kastrati, J. Mehilli, 2015, Clinical Research in Cardiology.

Prognostic value of glomerular function estimated by Cockcroft-Gault creatinine clearance, MDRD-4, CKD-EPI and European Kidney Function Consortium equations in patients with acute coronary syndromes.

H. Schunkert, M. Joner, A. Kastrati, 2021, Clinica chimica acta; international journal of clinical chemistry.

CORONARY ARTERY DISEASE Original Studies Angiographic Outcomes With Biodegradable Polymer and Permanent Polymer Drug-Eluting Stents

A. Kastrati, J. Mehilli, A. Schömig, 2011 .

Angiographic outcomes with biodegradable polymer and permanent polymer drug‐eluting stents

A. Kastrati, J. Mehilli, A. Schömig, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Histopathology-Based Deep-Learning Predicts Atherosclerotic Lesions in Intravascular Imaging

M. Joner, A. Kastrati, C. Marr, 2021, Frontiers in Cardiovascular Medicine.

Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus

H. Schunkert, M. Joner, A. Kastrati, 2021, Journal of the American Heart Association.

Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results

J. Mehilli, S. Kufner, K. Laugwitz, 2009, Heart.

Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.

H. Schunkert, M. Joner, A. Kastrati, 2023, European heart journal.

Rehospitalization Events After Aortic Valve Replacement: Insights From the PARTNER Trial

H. Schunkert, M. Joner, A. Kastrati, 2022, Circulation. Cardiovascular interventions.

Ten-year clinical outcomes of drug-eluting stents with different polymer coating strategies by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials.

H. Schunkert, M. Joner, A. Kastrati, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Long‐term prognostic value of risk scores after drug‐eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR‐LEFT‐MAIN and ISAR‐LEFT‐MAIN 2 randomized clinical trials

H. Schunkert, A. Kastrati, J. Mehilli, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation

H. Schunkert, M. Joner, A. Kastrati, 2022, Circulation. Cardiovascular interventions.

Machine learning identifies pathophysiologically and prognostically informative phenotypes among patients with mitral regurgitation undergoing transcatheter edge-to-edge repair.

H. Schunkert, M. Joner, A. Kastrati, 2023, European heart journal. Cardiovascular Imaging.

Clinical safety and efficacy of new-generation single-layer polytetrafluorethylene covered coronary stents.

H. Schunkert, A. Kastrati, R. Tölg, 2023, Cardiovascular revascularization medicine : including molecular interventions.

10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents.

H. Schunkert, M. Joner, A. Kastrati, 2020, Journal of the American College of Cardiology.

Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents: 5-Year Results of the ISAR-TEST-5 Trial.

A. Kastrati, J. Mehilli, Raphaela Lohaus, 2016, JACC. Cardiovascular interventions.

Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial.

H. Schunkert, A. Kastrati, S. Kufner, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.

H. Schunkert, A. Kastrati, F. Neumann, 2015, JACC. Cardiovascular interventions.

A pan-coronary artery angiographic study of the association between diabetes mellitus and progression or regression of coronary atherosclerosis

H. Schunkert, A. Kastrati, G. Ndrepepa, 2017, Heart and Vessels.

Impact of inhospital stent thrombosis and cerebrovascular accidents on long-term prognosis after percutaneous coronary intervention.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2014, American heart journal.

Efficacy of drug‐coated balloon angioplasty in early versus late occurring drug‐eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials

A. Kastrati, K. Mayer, R. Tölg, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate.

H. Schunkert, M. Joner, A. Kastrati, 2021, JACC: Cardiovascular Interventions.

Long‐term clinical outcomes after drug eluting stent implantation with and without stent overlap

H. Schunkert, M. Joner, A. Kastrati, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A. Kastrati, G. Ndrepepa, S. Kufner, 2015, European journal of clinical investigation.

Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease: Results From the ISAR-TEST 4 Randomized Trial

H. Schunkert, M. Joner, A. Kastrati, 2019, Circulation.

Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials

H. Schunkert, M. Joner, A. Kastrati, 2018, European heart journal cardiovascular Imaging.

Randomised comparison of vascular response to biodegradable polymer sirolimus eluting and permanent polymer everolimus eluting stents: An optical coherence tomography study.

M. Joner, A. Kastrati, T. Tada, 2018, International journal of cardiology.

Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease

H. Schunkert, M. Joner, A. Kastrati, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Five‐year clinical outcomes of sirolimus‐eluting versus paclitaxel‐eluting stents in high‐risk patients

Karl-Ludwig Laugwitz, Adnan Kastrati, Albert Schömig, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Postprocedural high-sensitivity troponin T and prognosis in patients with non-ST-segment elevation myocardial infarction treated with early percutaneous coronary intervention.

L. Räber, A. Kastrati, S. Windecker, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials.

H. Schunkert, M. Joner, A. Kastrati, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial.

H. Schunkert, M. Joner, A. Kastrati, 2021, JAMA cardiology.

Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016 .

H. Schunkert, A. Kastrati, J. Mehilli, 2017 .

CORONARY ARTERY DISEASE Original Studies Second-Versus First-Generation ‘‘Limus’’-Eluting Stents in Diabetic Patients with Coronary Artery Disease: A Randomized Comparison in Setting of ISAR-TEST-4 Trial

A. Kastrati, J. Mehilli, J. Pache, 2013 .

A. Kastrati, J. Mehilli, A. Schömig, 2010, Journal of the American College of Cardiology.

Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial.

C. Hengstenberg, H. Schunkert, M. Joner, 2014, JAMA.

Procedural and clinical performance of dual‐ versus single‐catheter strategy for transradial coronary angiography: A meta‐analysis of randomized trials

A. Kastrati, G. Ndrepepa, U. Landmesser, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ten‐year outcomes after percutaneous coronary intervention of in‐stent restenosis in saphenous vein grafts

A. Kastrati, S. Kufner, T. Ibrahim, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.

H. Schunkert, M. Joner, A. Kastrati, 2018, Journal of the American College of Cardiology.

Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents

M. Fischer, H. Schunkert, A. Kastrati, 2017, Thrombosis and Haemostasis.

Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis

H. Schunkert, M. Joner, A. Kastrati, 2019, Clinical Research in Cardiology.

Aspirin loading and coronary no-reflow after percutaneous coronary intervention in patients with acute myocardial infarction.

G. Ndrepepa, S. Kufner, K. Laugwitz, 2024, European journal of clinical investigation.

Early Aspirin Discontinuation After Coronary Stenting: A Systematic Review and Meta‐Analysis

M. Joner, A. Kastrati, G. Ndrepepa, 2021, Journal of the American Heart Association.

Prevalence and patterns of in-stent neoatherosclerosis in lower extremity artery disease.

M. Joner, A. Kastrati, S. Kufner, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Long-Term Ef fi cacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis 3-Year Results of a Randomized Controlled Trial

H. Schunkert, A. Kastrati, F. Neumann, 2022 .

Very long-term outlook of acute coronary syndromes after percutaneous coronary intervention with implantation of polymer-free versus durable-polymer new-generation drug-eluting stents.

H. Schunkert, M. Joner, A. Kastrati, 2023, Minerva medica.

Body mass index and efﬁcacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes

G. Ndrepepa, D. Angiolillo, D. Sibbing, 2022 .